EP1793865 - GENE OR DRUG DELIVERY SYSTEM [Right-click to bookmark this link] | Status | The application is deemed to be withdrawn Status updated on 27.05.2016 Database last updated on 24.08.2024 | Most recent event Tooltip | 27.05.2016 | Application deemed to be withdrawn | published on 29.06.2016 [2016/26] | Applicant(s) | For all designated states Baylor Research Institute 3434 Live Oak Street Dallas, TX 75204 / US | For all designated states Board of Regents, The University of Texas System 201 West Seventh Street Austin, TX 78701 / US | [N/P] |
Former [2007/24] | For all designated states Baylor Research Institute 3434 Live Oak Street Dallas, TX 75204 / US | ||
For all designated states Board of Regents, The University of Texas System 201 West Seventh Street Austin TX 78701 / US | Inventor(s) | 01 /
GRAYBURN, Paul, A. 2710 Lawtherwood Court Dallas, Texas 75214 / US | 02 /
CHEN, Shuyuan 1518 Streams Way Allen, TX 75002 / US | [2010/30] |
Former [2007/24] | 01 /
GRAYBURN, Paul, A. 1405 Sagewood Drive DeSoto, TX 75115 / US | ||
02 /
CHEN, Shuyuan 1518 Streams Way Allen, TX 75002 / US | Representative(s) | SONN Patentanwälte GmbH & Co KG Riemergasse 14 1010 Wien / AT | [N/P] |
Former [2007/24] | Sonn & Partner Patentanwälte Riemergasse 14 1010 Wien / AT | Application number, filing date | 05858371.7 | 05.08.2005 | [2007/24] | WO2005US28083 | Priority number, date | US20040599204P | 05.08.2004 Original published format: US 599204 P | [2007/24] | Filing language | EN | Procedural language | EN | Publication | Type: | A2 Application without search report | No.: | WO2007008220 | Date: | 18.01.2007 | Language: | EN | [2007/03] | Type: | A2 Application without search report | No.: | EP1793865 | Date: | 13.06.2007 | Language: | EN | The application published by WIPO in one of the EPO official languages on 18.01.2007 takes the place of the publication of the European patent application. | [2007/24] | Search report(s) | International search report - published on: | US | 07.02.2008 | (Supplementary) European search report - dispatched on: | EP | 14.04.2009 | Classification | IPC: | A61B8/00, A61K38/00 | [2008/12] | CPC: |
A61K9/127 (EP,US);
A61K41/0028 (EP,US);
A61K48/0075 (EP,US);
A61K9/0019 (EP,US);
A61K9/1272 (EP,US);
A61K9/1274 (EP,US);
A61P35/00 (EP)
(-)
|
Former IPC [2007/24] | A61K48/00 | Designated contracting states | AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HU, IE, IS, IT, LI, LT, LU, LV, MC, NL, PL, PT, RO, SE, SI, SK, TR [2007/24] | Extension states | AL | Not yet paid | BA | Not yet paid | HR | Not yet paid | MK | Not yet paid | YU | Not yet paid | Title | German: | SYSTEM ZUR GEN- ODER ARZNEIMITTELABGABE | [2007/24] | English: | GENE OR DRUG DELIVERY SYSTEM | [2007/24] | French: | SYSTEME DE DISTRIBUTION DE MEDICAMENT OU DE GENE | [2007/24] | Entry into regional phase | 20.02.2007 | National basic fee paid | 20.02.2007 | Search fee paid | 20.02.2007 | Designation fee(s) paid | 20.02.2007 | Examination fee paid | Examination procedure | 20.02.2007 | Amendment by applicant (claims and/or description) | 20.02.2007 | Examination requested [2007/24] | 27.07.2009 | Despatch of a communication from the examining division (Time limit: M04) | 30.11.2009 | Reply to a communication from the examining division | 19.03.2013 | Despatch of a communication from the examining division (Time limit: M06) | 13.09.2013 | Reply to a communication from the examining division | 06.07.2015 | Despatch of a communication from the examining division (Time limit: M06) | 19.01.2016 | Application deemed to be withdrawn, date of legal effect [2016/26] | 12.02.2016 | Despatch of communication that the application is deemed to be withdrawn, reason: reply to the communication from the examining division not received in time [2016/26] | Divisional application(s) | The date of the Examining Division's first communication in respect of the earliest application for which a communication has been issued is 27.07.2009 | Fees paid | Renewal fee | 13.08.2007 | Renewal fee patent year 03 | 28.03.2008 | Renewal fee patent year 04 | 14.08.2009 | Renewal fee patent year 05 | 31.08.2010 | Renewal fee patent year 06 | 05.08.2011 | Renewal fee patent year 07 | 09.08.2012 | Renewal fee patent year 08 | 19.08.2013 | Renewal fee patent year 09 | 13.08.2014 | Renewal fee patent year 10 | Penalty fee | Additional fee for renewal fee | 31.08.2015 | 11   M06   Not yet paid |
Opt-out from the exclusive Tooltip competence of the Unified Patent Court | See the Register of the Unified Patent Court for opt-out data | ||
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court. | Documents cited: | Search | [XY]WO0191805 (BRACCO RES USA [US], et al) [X] 1-7,9-11,16-22,28,29 * page 28, line 1 - page 51, line 18; claim - * [Y] 1-30; | [XY]WO03015831 (BRISTOL MYERS SQUIBB PHARMA CO [US]) [X] 1,6,9-11,17-21,29 * page 7, paragraph 1 - page 8, paragraph 5; claim - * [Y] 1-30; | [XY] - SEEMANN S ET AL, "Pharmaceutical evaluation of gas-filled microparticles as gene delivery system", PHARMACEUTICAL RESEARCH (NEW YORK), (200203), vol. 19, no. 3, ISSN 0724-8741, pages 250 - 257, XP002521569 [X] 19-21,23,28 * abstract; page 251, left-hand column, paragraph 2; discussion; * [Y] 1-30 DOI: http://dx.doi.org/10.1023/A:1014430631844 | [PXY] - KORPANTY G ET AL, "Targeting of VEGF-mediated angiogenesis to rat myocardium using ultrasonic destruction of microbubbles", GENE THERAPY, (20050414), vol. 12, no. 17, ISSN 0969-7128, pages 1305 - 1312, XP002521570 [PX] 1-11,14-23,26-29 * abstract; materials and methods; * [PY] 1-30 DOI: http://dx.doi.org/10.1038/sj.gt.3302532 | [Y] - EPSTEIN P N ET AL, "Expression of yeast hexokinase in pancreatic beta cells of transgenic mice reduces blood glucose, enhances insulin secretion, and decreases diabetes", PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, (1992), vol. 89, no. 24, ISSN 0027-8424, pages 12038 - 12042, XP002521610 [Y] 8,12,13,23-25 * abstract; materials and methods; * DOI: http://dx.doi.org/10.1073/pnas.89.24.12038 | [Y] - ISHIHARA H ET AL, "Overexpression of Hexokinase I but not GLUT1 Glucose Transporter Alters Concentration Dependence of Glucose-stimulated Insulin Secretion in Pancreatic beta-Cell Line MIN6", JOURNAL OF BIOLOGICAL CHEMISTRY, (1994), vol. 269, no. 4, ISSN 0021-9258, pages 3081 - 3087, XP002521611 [Y] 8,12,13,23-25 * abstract; experimental procedures; * | [T] - CHEN S ET AL, "Efficient gene delivery to pancreatic islets with ultrasonic microbubble destruction technology", PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, (200605), vol. 103, no. 22, ISSN 0027-8424, pages 8469 - 8474, XP002521571 [T] 1-30 * the whole document * DOI: http://dx.doi.org/10.1073/PNAS.0602921103 | International search | [X]US5580575 (UNGER EVAN C [US], et al); | [Y]US6486380 (EPSTEIN PAUL N [US]); | [Y]US6521211 (UNGER EVAN C [US], et al); | [Y]US2004086485 (AGUILAR-CORDOVA CARLOS ESTUARD [US]) |